The 3 most recent market catalysts affecting $OSUR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 75
OraSure Technologies Sees Q3 Sales $29.500M-$32.500M vs $31.143M Est
OraSure Technologies (OSUR) has released its Q3 sales guidance, projecting a range of $29.5 million to $32.5 million. This guidance is significant because it provides an early indi…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 75
OraSure Technologies Q2 Adj. EPS $(0.20) Beats $(0.27) Estimate, Sales $30.639M Beat $29.064M Estimate
This headline is a significant corporate catalyst for OraSure Technologies (OSUR). Beating both EPS and sales estimates indicates better-than-anticipated financial health and poten…
Jul 21, 2026
Corporate Catalyst
Bullish
Impact 65
OraSure Technologies Receives FDA's Emergency Use Authorization For Its OraQuick Ebola 2.0 Rapid Antigen Test
OraSure Technologies (OSUR) has secured an Emergency Use Authorization from the FDA for its OraQuick Ebola 2.0 Rapid Antigen Test. This authorization is a significant corporate cat…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.